| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |